Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Opioids were once the go-to solution for surgical pain relief, but unwanted side effects like nausea, dizziness, constipation ...

By Christopher McNamaraPCFA Clinical Nurse Specialist - Sexual Function Programs LeaderDid you know that more than half of ...

The first-of-its-kind drug doesn’t just regrow hair—it could cure premature graying, too. An old wives’ tale claims male ...

The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...

Nasacort takes up to a week to achieve full benefits for allergy symptoms, and should be used daily for optimal allergy ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.

Distraction methods, such as use of a stress ball, are simple and effective strategies for reducing perceived stress and pain in patients during port catheter needle insertion. Distraction methods are ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Combining 177 Lu-PSMA-617 with SOC produced statistically significant rPFS, reducing the risk of radiographic progression or death by 28% (HR 0.72; 95% CI, 0.58-0.90) vs SOC alone in patients with ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...